-
LAVA Therapeutics Stock Drops After Amended Deal With XOMA Royalty
17 Oct 2025 20:18 GMT
… 23 per CVR.
LAVA and XOMA Royalty also agreed to amend … related to the deal with XOMA Royalty on November 7, after … XOMA. XOMA first announced that it would acquire LAVA in August.
LAVA shares … While LVTX shares have gained 56% this year, XOMA stock has risen …
-
XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement
17 Oct 2025 15:45 GMT
… NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA) and LAVA … in XOMA Royalty acquiring 100% of the shares in … ), including insufficient ordinary shares of LAVA being tendered … DECISION REGARDING TENDERING THEIR SHARES (INCLUDING THE TERMS …
-
Xoma extends offer to acquire Lava Therapeutics
03 Oct 2025 03:52 GMT
… to purchase all outstanding shares of common shares of Lava, for a … the tender of Lava common shares representing at least 80% … Lava’s issued and outstanding shares, the condition that certain … to result in Xoma Royalty acquiring 100% of the shares in Lava …
-
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
02 Oct 2025 20:43 GMT
… NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA … purchase all outstanding shares of common shares of LAVA, for … in XOMA Royalty acquiring 100% of the shares in … DECISION REGARDING TENDERING THEIR SHARES (INCLUDING THE TERMS AND …
-
XOMA Royalty Declares Quarterly Preferred Stock Dividends
22 Sep 2025 11:30 GMT
… shares, each representing 1/1000 of a share of XOMA … 2025. About XOMA Royalty Corporation
XOMA Royalty is … Contact
Juliane Snowden
XOMA Royalty Corporation
+1- …
juilane.snowden@xoma.com
XOMA Royalty Media Contact …
-
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.
17 Sep 2025 13:00 GMT
… (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company … Expiration Date, the number of shares validly tendered in accordance with … Expiration Date, XOMA Royalty irrevocably accepted for payment all shares validly tendered …
-
XOMA Royalty Subsidiary to Acquire Mural Oncology in Premium Cash Transaction
22 Aug 2025 04:34 GMT
… review value, highlighting shareholder upside.
XOMA 2025 Growth Strategy: Acquisition adds … Acquisition Portfolio
The deal underscores XOMA’s aggressive acquisition streak in … conditions, including a majority of shares being tendered, Turnstone maintaining a …
-
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
20 Aug 2025 12:49 GMT
… than any Mural Shares beneficially owned by XOMA Royalty or its subsidiaries … company limited by shares or, if legally permitted, XOMA Royalty will seek … than any Mural Shares beneficially owned by XOMA Royalty or is subsidiaries …
-
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
20 Aug 2025 12:30 GMT
… than any Mural Shares beneficially owned by XOMA Royalty or its subsidiaries … company limited by shares or, if legally permitted, XOMA Royalty will seek … than any Mural Shares beneficially owned by XOMA Royalty or is subsidiaries …
-
XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements
13 Aug 2025 11:30 GMT
… repurchased approximately 81,700 shares of XOMA Royalty common stock for … repurchased approximately 107,500 shares of its common stock … $
0.27
Weighted average shares used in computing diluted net … 3,600 shares authorized, 1,600 shares issued and outstanding …